8:22 AM
Leo Group India
| ||
| Supreme Court to review lawsuits over flaws in generic drugs Reuters India The court agreed to review a bid by Mutual Pharmaceutical Co to overturn a $21 million jury award to Karen Bartlett, a New Hampshire woman who had taken its generic non-steroidal anti-inflammatory drug sulindac for shoulder pain. Bartlett was left with ... See all stories on this topic » | ||
| Ranbaxy stops generic Lipitor production amid recall CBS News Ranbaxy Pharmaceuticals Inc. has halted all production of the generic cholesterol-lowering drug Lipitor while it investigates how tiny glass particles got into dozens of batches of the drug. The Food and Drug Administration said Ranbaxy, a subsidiary ... See all stories on this topic » | ||
| 4 Pharmaceutical Stocks to Buy Now Investorplace.com This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). This week, Acura Pharmaceuticals (NASDAQ:ACUR) is showing significant improvement ... See all stories on this topic » | ||
| Buckingham Research Cuts Teva Pharmaceutical Industries Ltd to Neutral (TEVA) Daily Political Teva Pharmaceutical Industries Ltd traded up 0.15% on Friday, hitting $40.28. Teva Pharmaceutical Industries Ltd has a 1-year low of $37.40 and a 1-year high of $46.65. The company has a market cap of $34.963 billion and a price-to-earnings ratio of 16.39. See all stories on this topic » | ||
| ||
| Mylan gets US FDA approval for generic Detrol tablets pharmabiz.com Mylan Inc's subsidiary Mylan Pharmaceuticals Inc. has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for tolterodine tartrate tablets, one mg and two mg. This product is the ... See all stories on this topic » | ||
| Cumberland Pharmaceuticals lays off one-third of sales force Nashville Business Journal Nashville-based Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) laid off one-third of its salesforce Thursday, according to a filing late Friday with the U.s. Securities and Exchange Commission. The company's sales personnel dropped from 95 to 64 ... See all stories on this topic » | ||
| Sucampo Announces Approval for Updates to AMITIZA; Endo Health Solutions ... Equities.com {nfg}Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) announced the Company received a supplement approval from the U.S. Food and Drug Administration (FDA) that removes pregnancy "warnings and precautions" and clarifies information regarding the ... See all stories on this topic » | ||
| Healthcare Sector Quick Snapshot; Johnson & Johnson (JNJ) Picks CEO Alex ... eStocksDaily Healthcare sector responded negatively on last trading session of the week and sector tumbled -0.08%. If we look at the key movers of the sector so Exelixis, Inc (NASDAQ:EXEL) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) were major percentage ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment